Picture of Shandong Weigao Medical Polymer Co logo

1066 Shandong Weigao Medical Polymer Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Annual cashflow statement for Shandong Weigao Medical Polymer Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

R2020
December 31st
R2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,5652,8783,3862,3692,554
Depreciation
Amortisation
Non-Cash Items160152-28318270.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-640-675-1,608-659-800
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,7883,0872,2952,7992,790
Capital Expenditures-1,007-1,166-1,117-686-647
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,391-352-1,430-703-457
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities384-1,518-2,547-1,389-1,104
Financing Cash Flow Items-84.6229-305-979-532
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,794-548-1,021-2,158-1,596
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,321966-1,177-724145